Management of Borderline Resectable Pancreatic Cancer

被引:49
|
作者
Katz, Matthew H. G. [1 ]
Crane, Christopher H. [2 ]
Varadhachary, Gauri [3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA
关键词
GEMCITABINE-BASED CHEMORADIATION; EXPERT CONSENSUS STATEMENT; PREOPERATIVE GEMCITABINE; RADIATION-THERAPY; MULTIINSTITUTIONAL PHASE-2; NEOADJUVANT GEMCITABINE; CONTROLLED-TRIAL; DOSE-ESCALATION; ADENOCARCINOMA; CHEMOTHERAPY;
D O I
10.1016/j.semradonc.2013.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Borderline resectable pancreatic cancers are those that, although technically resectable, are at high risk for margin-positive resection following surgery de novo. Generally, such cancers are characterized by localized primary tumors that involve the mesenteric vasculature to a limited degree and that may require venous or hepatic arterial resection at pancreatectomy. In this article, we review diagnosis and staging algorithms, pretreatment strategies, and multidisciplinary treatment protocols for patients with this stage of disease. The rationale for and results following treatment with neoadjuvant chemotherapy and chemoradiation and subsequent surgical resection of the primary tumor are described in detail and existing data are reviewed. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [41] Defining and Treating Borderline Resectable Pancreatic Cancer
    Perri, Giampaolo
    Prakash, Laura
    Katz, Matthew H. G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (09)
  • [42] Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress
    Wu, Hong-Yu
    Li, Jin-Wei
    Li, Jin-Zheng
    Zhai, Qi-Long
    Ye, Jing-Yuan
    Zheng, Si-Yuan
    Fang, Kun
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (02): : 142 - 162
  • [43] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [44] Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer
    Neoptolemos, John P.
    Ghaneh, Paula
    Hackert, Thilo
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 714 - 716
  • [45] Current Value of Perioperative Therapies for Resectable or Borderline Resectable Pancreatic Cancer
    Murakami, Yuki
    Sakamoto, Teruhisa
    Hanaki, Takehiko
    Tokuyasu, Naruo
    Fujiwara, Yoshiyuki
    YONAGO ACTA MEDICA, 2023, 66 (02) : 202 - 207
  • [46] New Developments in the Management of Borderline Resectable Pancreatic Cancers
    Goodman, Martin D.
    McPartland, Sarah
    Huber, Kathryn
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (04): : 334 - 336
  • [47] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [48] Characteristics and Outcomes of Borderline Resectable Pancreatic Cancer Compared with Resectable Disease
    Thomas, A.
    Melling, J.
    Jackson, R.
    Whelan, P.
    Sykes, P.
    Jones, O.
    Smith, R.
    Campbell, F.
    Evans, J.
    Raraty, M.
    Halloran, C.
    Sutton, R.
    Neoptolemos, J.
    Ghaneh, P.
    PANCREAS, 2013, 42 (08) : 1386 - 1386
  • [49] Neoadjuvant Treatment in Locally Advanced and Borderline Resectable Pancreatic Cancer vs Primary Resectable Pancreatic Cancer
    Del Chiaro, Marco
    Valente, Roberto
    Arnelo, Urban
    JAMA SURGERY, 2017, 152 (11) : 1057 - 1057
  • [50] Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer
    Helmink, Beth A.
    Snyder, Rebecca A.
    Idrees, Kamran
    Merchant, Nipun B.
    Parikh, Alexander A.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (02) : 287 - +